Latest MECP2 Stories
Head growth significantly improved in placebo-controlled trial MOUNTAIN VIEW, Calif., Sept.
VANCOUVER, British Columbia, May 5, 2014 /PRNewswire-USNewswire/ -- A pediatric neurologist whose breakthrough research identified genetic mutations that cause Rett syndrome and many other neurological
In research published today in Molecular Psychiatry, a multinational team of scientists presents new evidence supporting the theory that in at least some cases of schizophrenia, autism and intellectual disability (ID), malfunctions in some of the same genes are contributing to pathology.
Despite the identification of gene mutations in methyl CpG binding protein 2 (MECP2) being linked to Rett syndrome (RS), research has been hindered by the lack of commercially available reference materials.
Continuing to expand the depth and breadth of high-impact research, the Rett Syndrome Research Trust (RSRT) awarded a record $7.2 million to new scientific explorations in 2013.
-- Bird identified DNA regions where genes are activated, a fundamental contribution in the field of epigenetics, which studies how environmental factors influence diseases such as cancer
Sometimes, when the DNA in a cell is copied during cell division, there is a mistake.
The concept behind gene therapy is simple: deliver a healthy gene to compensate for one that is mutated.
Statins, a class of cholesterol-lowering drugs found in millions of medicine cabinets, may help treat Rett Syndrome.
- totally perplexed and mixed up.